Valuation: ResMed Inc.

Market Cap 32.76B 29.25B 26.84B 24.42B 45.78B 3,102B 46.69B 321B 129B 1,637B 123B 120B 5,171B P/E 2027 *
19.5x
P/E 2028 * 17.8x
Enterprise Value 31.87B 28.45B 26.11B 23.75B 44.53B 3,017B 45.41B 312B 126B 1,592B 120B 117B 5,030B EV / Sales 2027 *
5.46x
EV / Sales 2028 * 5.05x
Free-Float
74.65%
Yield 2027 *
1.16%
Yield 2028 * 1.26%
1 day-1.46%
1 week-7.13%
Current month-7.15%
1 month+4.37%
3 months+8.96%
6 months+13.85%
Current year-8.26%
1 week 32.53
Extreme 32.53
37.67
1 month 31.52
Extreme 31.52
37.67
Current year 25.5
Extreme 25.5
39.1
1 year 25.5
Extreme 25.5
39.94
3 years 22.19
Extreme 22.19
45.25
5 years 21.14
Extreme 21.14
45.25
10 years 7.15
Extreme 7.15
45.25
Manager TitleAgeSince
Chief Executive Officer 54 2013-02-28
Director of Finance/CFO 41 2026-05-03
Chief Tech/Sci/R&D Officer - 2024-01-31
Director TitleAgeSince
Director/Board Member 78 2004-12-31
Chairman 54 2023-01-24
Chairman 84 1989-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.46%-7.13% - - 32.34B
-2.06%-0.33%+20.31%+52.52% 258B
-1.83%-2.15%+5.85%+18.13% 163B
+1.12%-3.27%-18.23%+57.21% 150B
+5.57%-2.76%-56.00%-15.61% 60.84B
+1.19%+2.62%-10.64%-8.42% 53.31B
+1.36%+2.98%+13.11%+42.32% 53.03B
-1.90%-3.51%+5.43%+61.66% 50.67B
-1.65%-2.26%+17.51%+64.63% 49.3B
-2.85%-1.41%+28.58%+83.18% 45.46B
Average -0.25%-1.09%+0.66%+39.51% 98.22B
Weighted average by Cap. -0.59%-1.28%+2.97%+40.76%

Financials

2027 *2028 *
Net sales 5.83B 5.21B 4.78B 4.35B 8.15B 552B 8.31B 57.09B 23.01B 292B 21.9B 21.43B 921B 6.2B 5.54B 5.08B 4.62B 8.66B 587B 8.84B 60.67B 24.46B 310B 23.27B 22.77B 979B
Net income 1.69B 1.51B 1.39B 1.26B 2.36B 160B 2.41B 16.56B 6.68B 84.57B 6.35B 6.22B 267B 1.82B 1.63B 1.49B 1.36B 2.54B 172B 2.59B 17.82B 7.18B 90.97B 6.83B 6.69B 287B
Net Debt -897M -801M -735M -668M -1.25B -84.91B -1.28B -8.78B -3.54B -44.81B -3.37B -3.29B -142B -1.43B -1.28B -1.18B -1.07B -2.01B -136B -2.05B -14.04B -5.66B -71.7B -5.39B -5.27B -226B
Projected Income Statement - Annual - ResMed Inc.
Logo ResMed Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Date Price Change Volume
26-11-02 A$32.97 -1.46% 2,044,178
26-11-02 A$33.46 -5.77% 4,025,488
26-10-30 A$35.51 +0.37% 2,628,627
26-10-29 A$35.38 +0.71% 1,912,360
26-10-28 A$35.13 -1.04% 2,189,739
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - ResMed Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
232.94USD
Average target price
265.11USD
Spread / Average Target
+13.81%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ResMed Inc.